Retinoids for ovarian cancer prevention: laboratory data set the stage for thoughtful clinical trials.
Veronesi
U
U
Decensi
A
A
D016588:Anticarcinogenic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D005260:Female; D017313:Fenretinide / Q000494:pharmacology / Q000627:therapeutic use; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D006801:Humans; D018396:Mucin-1 / Q000096:biosynthesis* / Q000187:drug effects*; D010051:Ovarian Neoplasms / Q000453:epidemiology / Q000378:metabolism / Q000517:prevention & control*; D012176:Retinoids / Q000494:pharmacology* / Q000627:therapeutic use; D015854:Up-Regulation / Q000187:drug effects
D016588:Anticarcinogenic Agents; D018396:Mucin-1; D012176:Retinoids; D017313:Fenretinide